Начало › Рак на белия дроб с недребноклетъчен тип › Ню Йорк › Queens
Клинични проучвания за Рак на белия дроб с недребноклетъчен тип в Queens, NY
49 проучвания за Рак на белия дроб с недребноклетъчен тип търсят участници в обекти в и около Queens (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 2
- Clinical Research Alliance - Westbury /ID# 270455, Westbury · на 14 мили
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набиране на участнициФаза 3
- Northwell Health/Center for Advanced Medicine, Lake Success · на 9 мили
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- START New York Long Island LLC, Lake Success · на 9 мили
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Набиране на участнициФаза 2
- Memorial Sloan Kettering Nassau, Uniondale · на 13 мили
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Набиране на участнициФаза 2/3
- NYU Langone Hospital Long Island, Mineola · на 11 мили
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Набиране на участнициФаза 3
- New York Cancer & Blood Specialists - New Hyde Park, New Hyde Park · на 9 мили
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Набиране на участнициФаза 3
- Optum Medical Care, PC, Westbury · на 14 мили
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Набиране на участнициФаза 3
- Local Institution - 0224, Laurelton · на 5 мили
- Optum Medical Care, PC, Westbury · на 14 мили
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Набиране на участнициФаза 3
- Optum Medical Care, PC, Westbury · на 14 мили
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Набиране на участнициФаза 3
- Research Site, Fresh Meadows · на 4 мили
- Research Site, Westbury · на 14 мили
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · на 11 мили
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Набиране на участнициФаза 2/3
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · на 11 мили
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Набиране на участнициФаза 1/2
- START New York, Lake Success · на 9 мили
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 3
- Research Site, Westbury · на 14 мили
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · на 13 мили
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Набиране на участнициФаза 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · на 13 мили
Using Urine Samples to Identify Lung Cancer
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · на 13 мили
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Набиране на участнициФаза 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · на 13 мили
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Набиране на участнициФаза 1
- Site 107 - START New York - Long Island, Lake Success · на 9 мили
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Набиране на участнициФаза 1/2
- NYU Langone Hospital - Long Island, Mineola · на 11 мили
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Набиране на участнициФаза 3
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · на 9 мили
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · на 11 мили
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Набиране на участнициФаза 3
- Clinical Research Alliance, Westbury · на 14 мили
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Набиране на участнициФаза 1
- NYU Langone Health - Long Island, Mineola · на 11 мили
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1
- START NY Long Island, Lake Success · на 9 мили
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Набиране на участнициФаза 1/2
- START New York Long Island, New Hyde Park · на 9 мили
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Набиране на участнициФаза 1
- Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola · на 11 мили
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Набиране на участници
- Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre · на 10 мили
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Набиране на участнициФаза 3
- Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success · на 9 мили
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Набиране на участнициФаза 3
- NYU Langone Hospital - Long Island, Mineola · на 11 мили
- Memorial Sloan Kettering Nassau, Uniondale · на 13 мили
A Study of MGC026 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- START-New York Long Island, Lake Success · на 9 мили
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Набиране на участнициФаза 2
- Memorial Sloan Kettering Nassau, Uniondale · на 13 мили
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Набиране на участнициФаза 1/2
- Northwell Health, Lake Success · на 9 мили
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Набиране на участнициФаза 3
- Queens Cancer Center, Rego Park · на 3 мили
- Northwell Health/Center for Advanced Medicine, Lake Success · на 9 мили
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · на 13 мили
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Набиране на участнициНаблюдателно проучване
- Memorial Sloan Kettering Nassau (Consent Only), Uniondale · на 13 мили
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Набиране на участнициФаза 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park · на 9 мили
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon · на 27 мили
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Набиране на участнициФаза 1/2
- Clinical Research Alliance, Westbury · на 14 мили
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Набиране на участнициФаза 3
- New York Cancer & Blood Specialists (NYCBS), New Hyde Park · на 9 мили
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Набиране на участнициФаза 1
- START New York Long Island, LLC, Lake Success · на 9 мили
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- START New York Long Island, LLC, Lake Success · на 9 мили
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · на 13 мили
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 2
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · на 10 мили
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Memorial Sloan Kettering Nassau, Uniondale · на 13 мили
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · на 10 мили
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · на 13 мили
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Набиране на участнициНаблюдателно проучване
- Queens Hospital Center, Jamaica · на 2 мили
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Набиране на участнициФаза 2
- Memorial Sloan Kettering Nassau, Uniondale · на 13 мили
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · на 10 мили
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, Hempstead · на 12 мили
Проучвания за Рак на белия дроб с недребноклетъчен тип в други градове
- Houston, TX145 проучвания
- New York City, NY121 проучвания
- Arlington, VA104 проучвания
- Nashville, TN97 проучвания
- Boston, MA90 проучвания
- Los Angeles, CA87 проучвания
- St. Louis, MO73 проучвания
- Chicago, IL61 проучвания
- Baltimore, MD60 проучвания
- San Antonio, TX59 проучвания
- Columbus, OH57 проучвания
- Washington, DC55 проучвания
Други проучвания в Queens
- Рак на гърдата64 проучвания
- Колоректален рак31 проучвания
- Метастатичен рак28 проучвания
- Рак на яйчниците28 проучвания
- Рак на простатата27 проучвания
- Рак (всички видове)26 проучвания
- Ендометриален рак25 проучвания
- Рак на белия дроб22 проучвания
- Остра миелоидна левкемия21 проучвания
- Множествен миелом20 проучвания
- Рак на панкреаса20 проучвания
- Плоскоклетъчен карцином на главата и шията20 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.